NO20076390L - Sammensetninger og medtoder for behandling av malaria med cupredoxin og cytokrom - Google Patents

Sammensetninger og medtoder for behandling av malaria med cupredoxin og cytokrom

Info

Publication number
NO20076390L
NO20076390L NO20076390A NO20076390A NO20076390L NO 20076390 L NO20076390 L NO 20076390L NO 20076390 A NO20076390 A NO 20076390A NO 20076390 A NO20076390 A NO 20076390A NO 20076390 L NO20076390 L NO 20076390L
Authority
NO
Norway
Prior art keywords
cytochrome
malaria
cupredoxin
compositions
malaria infection
Prior art date
Application number
NO20076390A
Other languages
English (en)
Norwegian (no)
Inventor
Ananda Chakrabarty
Tapas Das Gupta
Tohru Yamada
Arsenio Fialho
Anita Chaudhari
Chang Soo Hong
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/244,105 external-priority patent/US7691383B2/en
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of NO20076390L publication Critical patent/NO20076390L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/80—Cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20076390A 2005-05-20 2007-12-11 Sammensetninger og medtoder for behandling av malaria med cupredoxin og cytokrom NO20076390L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68281305P 2005-05-20 2005-05-20
US11/244,105 US7691383B2 (en) 2004-10-07 2005-10-06 Cupredoxin derived transport agents and methods of use thereof
US78086806P 2006-03-10 2006-03-10
PCT/US2006/019492 WO2006127477A2 (en) 2005-05-20 2006-05-19 Compositions and methods for treating malaria with cupredoxin and cytochrome

Publications (1)

Publication Number Publication Date
NO20076390L true NO20076390L (no) 2008-02-15

Family

ID=37452644

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076390A NO20076390L (no) 2005-05-20 2007-12-11 Sammensetninger og medtoder for behandling av malaria med cupredoxin og cytokrom

Country Status (10)

Country Link
EP (1) EP1882039A4 (pt)
JP (1) JP2009504567A (pt)
KR (1) KR20080019615A (pt)
AU (2) AU2006251742A1 (pt)
BR (1) BRPI0612456A2 (pt)
CA (1) CA2607739A1 (pt)
IL (1) IL187161A0 (pt)
MX (1) MX2007014597A (pt)
NO (1) NO20076390L (pt)
WO (1) WO2006127477A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
MX2007014599A (es) * 2005-05-20 2008-02-07 Univ Illinois Composiciones y metodos para el tratamiento de infeccion por vih con cupredoxina y citocromo c.
MX2008000993A (es) * 2005-07-19 2008-03-19 Univ Illinois Composiciones y metodos para controlar la angiogenesis con cupredoxinas.
AU2006269879A1 (en) 2005-07-19 2007-01-25 The Board Of Trustees Of The University Of Illinois Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
WO2002070542A2 (en) * 2001-03-02 2002-09-12 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Band 3 antigenic peptides, malaria polypeptides and uses thereof

Also Published As

Publication number Publication date
WO2006127477A2 (en) 2006-11-30
BRPI0612456A2 (pt) 2009-02-17
IL187161A0 (en) 2008-02-09
JP2009504567A (ja) 2009-02-05
MX2007014597A (es) 2008-01-21
EP1882039A4 (en) 2008-08-20
KR20080019615A (ko) 2008-03-04
AU2010201360A1 (en) 2010-04-29
CA2607739A1 (en) 2006-11-30
WO2006127477A3 (en) 2007-03-08
EP1882039A2 (en) 2008-01-30
AU2006251742A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
MA30063B1 (fr) Derives pyrimidinyl-aryluree constituant des inhibiteurs des facteurs de croissance des fibroblastes (fcg)
EA201001508A1 (ru) Мостиковые гетероциклические соединения в качестве ингибиторов интегразы вич
MY138341A (en) Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use
BRPI0512397A (pt) composto,produto farmacêutico, métodos para suprimir a metástase de cáncer ou o crescimento do cáncer, para prevenir ou tratar uma doença ou condição, para controlar a função placentária, para melhorar a função gonadal, para induzir ou estimular a ovulação, para promover a secreção do hormÈnio gonadotrópico ou promover a secreção do hormÈnio sexual, para suprimir a secreção do hormÈnio gonadotrópico ou suprimir a secreção do hormÈnio sexual, para infra regular hormÈnio gonadrotópico ou hormÈnio sexual, e a proteìna ot7t175 humana, e para realçar a estabilidade no sangue, uso do composto, e, agente para suprimir a secreção do hormÈnio gonadotrópico ou um agente para suprimir a secreção do hormÈnio sexual
Langleben et al. STRIDE 1: effects of the selective ETA receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials
WO2006076506A3 (en) Treating a diseased nail
EA200702493A1 (ru) Соединения и способы лечения или предотвращения флавивирусных инфекций
NO20061479L (no) Anvendelse av modifiserte cyklosporiner for behandling av HCV-forstyrrelser
EA201001273A1 (ru) Ингибиторы вируса гепатита с
EA201100814A1 (ru) Фармацевтические формы применения, содержащие нифедипин или низолдипин и антагонист ангиотензина-ii и/или диуретик
MX2010005292A (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana.
NO20073367L (no) Makrolider
WO2009152147A3 (en) Compositions and methods for dengue virus (dv) treatment and vaccination
TW200718358A (en) Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
CY1118073T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης
EA201001668A1 (ru) Ингибитор белка, активирующего 5-липоксигеназу
NO20076390L (no) Sammensetninger og medtoder for behandling av malaria med cupredoxin og cytokrom
MXPA05012392A (es) Tratamientos de ansiedad con ziprasidona.
RU2017113775A (ru) Применение нейрегулина в профилактике, лечении или отсрочке развития желудочковой аритмии и его композиция
EP2251013A3 (en) Use of inositol-tripyrophosphate in treating Alzheimer's disease, stroke or osteoporosis
Vathsala et al. Immunomodulatory and antiparasitic effects of garlic–arteether combination via nitric oxide pathway in Plasmodium berghei-infected mice
EA201001748A1 (ru) Соединения, используемые для лечения гепатита с
BRPI0519355A2 (pt) compostos para tratamento contra flaviviridae
WO2021232165A1 (en) Recoded oncolytic viruses for treatment of cancer
Troye-Blomberg et al. Immune interactions in malaria co-infections with other endemic infectious diseases: implications for the development of improved disease interventions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application